Differential Ire1 determines loser cell fate in tumor-suppressive cell competition.
CP: Cell biology
Drosophila
E-cad
Ire1
UPR
apoptosis
autophagy
cell competition
scribble
tumor
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
28 Nov 2023
28 Nov 2023
Historique:
received:
07
02
2023
revised:
31
08
2023
accepted:
03
10
2023
medline:
4
12
2023
pubmed:
4
11
2023
entrez:
4
11
2023
Statut:
ppublish
Résumé
Tumor-suppressive cell competition (TSCC) is a conserved surveillance mechanism in which neighboring cells actively eliminate oncogenic cells. Despite overwhelming studies showing that the unfolded protein response (UPR) is dysregulated in various tumors, it remains debatable whether the UPR restrains or promotes tumorigenesis. Here, using Drosophila eye epithelium as a model, we uncover a surprising decisive role of the Ire1 branch of the UPR in regulating cell polarity gene scribble (scrib) loss-induced TSCC. Both mutation and hyperactivation of Ire1 accelerate elimination of scrib clones via inducing apoptosis and autophagy, respectively. Unexpectedly, relative Ire1 activity is also crucial for determining loser cell fate, as dysregulating Ire1 signaling in the surrounding healthy cells reversed the "loser" status of scrib clones by decreasing their apoptosis. Furthermore, we show that Ire1 is required for cell competition in mammalian cells. Together, these findings provide molecular insights into scrib-mediated TSCC and highlight Ire1 as a key determinant of loser cell fate.
Identifiants
pubmed: 37924514
pii: S2211-1247(23)01315-3
doi: 10.1016/j.celrep.2023.113303
pii:
doi:
Substances chimiques
Drosophila Proteins
0
inositol requiring enzyme-1, Drosophila
EC 3.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113303Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.